Kevin Balthaser
Fortune : 852 911 $ au 31/05/2026
Fortune : 852 911 $ au 31/05/2026
Kevin Balthaser currently holds the position of Chief Financial Officer & Accounting Officer at Aclaris Therapeutics, Inc. since 2023 and has been with the company since 2017.
Kevin is also a member of The American Institute of Certified Public Accountants.
Mr. Balthaser completed undergraduate studies at The Pennsylvania State University and earned an MBA from Villanova University in 1990.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/04/2026 | 187 453 ( 0,13% ) | 852 911 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Directeur Financier/CFO | 01/01/2023 |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national